Congress:
ECR25
Poster Number:
C-14461
Type:
Poster: EPOS Radiologist (educational)
Authorblock:
M. Hovsepian, J. San Roman, C. Collaud, G. B. Amorin, N. Pabstleben; Buenos Aires/AR
Disclosures:
Magali Hovsepian:
Nothing to disclose
Jose San Roman:
Nothing to disclose
Carlos Collaud:
Nothing to disclose
Gabriela Beatriz Amorin:
Nothing to disclose
Nadia Pabstleben:
Nothing to disclose
Keywords:
Hybrid Imaging, Molecular imaging, Neuroradiology brain, PET-CT, Molecular imaging, Dementia, Motility
- To emphasize the clinical and therapeutic significance of distinguishing Parkinson’s disease (PD) from other Parkinsonian syndromes (PS).
- To illustrate the normal and abnormal patterns of striatal 18F-DOPA uptake in brain PET scans.
- To study the role of 18F-DOPA as an in vivo biomarker to differentiate PD from other PS.
- To review current indications of brain 18F-DOPA PET/CT in patients with PS.